OrganOx.jpg
OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting
12. November 2024 08:00 ET | ORGANOX LIMITED; eGenesis, Inc.
OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting
OrganOx.jpg
Appointment of Stephen M. Deitsch as new Chief Financial Officer
04. April 2024 11:43 ET | ORGANOX LIMITED
OrganOx Appoints Stephen M. Deitsch, an experienced medtech finance leader with proven track record with IPOs, as new Chief Financial Officer.
OrganOx.jpg
OrganOx Raises £25 Million in Growth Round Led by Lauxera Capital Partners
17. Juli 2023 02:05 ET | ORGANOX LIMITED
OXFORD, United Kingdom, July 17, 2023 (GLOBE NEWSWIRE) -- OrganOx Ltd (“OrganOx” or the “Company”), a world-leading medical technology company committed to making every donated organ count with...
TIP_link_300x300.jpg
Medical Perfusion Technology Market to Outstrip $962.60 Million by 2027 Growing Sturdy at 4.1% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com
22. Juni 2021 11:32 ET | The Insight Partners
Pune, India., June 22, 2021 (GLOBE NEWSWIRE) -- Medical Perfusion Technology Market: Key InsightsAccording to our new research study on “Medical Perfusion Technology Market to 2027 – Global Analysis...